Zydus Lifesciences Limited
NSE:ZYDUSLIFE.NS
970.35 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Zydus Lifesciences Limited |
Symbool | ZYDUSLIFE.NS |
Munteenheid | INR |
Prijs | 970.35 |
Beurswaarde | 976,395,280,500 |
Dividendpercentage | 0.6% |
52-weken bereik | 606.05 - 1,324.3 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Sharvil Pankajbhai Patel |
Website | https://www.zyduslife.com |
An error occurred while fetching data.
Over Zydus Lifesciences Limited
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments. It offers finished dosage human formulations comprising generics, branded generics, and specialty
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)